Bank of America
YARW

Bank of America’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Bank of America’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-34
Closed -$973 – 6903
2025
Q4 		$973 Buy
34
+3
+10% +$60 ﹤0.01% 6463
2025
Q3 		$513 Buy
31
+2
+7% +$65 ﹤0.01% 7584
2025
Q2 		$2.42K Sell
29
-314
-92% -$20.4K ﹤0.01% 7408
2025
Q1 		$27.1K Buy
343
+313
+1,043% +$38.5K ﹤0.01% 6882
2024
Q4 		$5K Sell
30
-16
-35% -$2.09K ﹤0.01% 7095
2024
Q3 		$4.28K Hold
46
– – ﹤0.01% 7033
2024
Q2 		$4.54K Buy
46
+2
+5% +$249 ﹤0.01% 7028
2024
Q1 		$6.71K Sell
44
-12
-21% -$1.29K ﹤0.01% 6958
2023
Q4 		$6.49K Sell
56
-12
-18% -$1.87K ﹤0.01% 6967
2023
Q3 		$13.8K Sell
68
-16
-19% -$3.49K ﹤0.01% 6787
2023
Q2 		$17.2K Sell
84
-11
-12% -$2.93K ﹤0.01% 6743
2023
Q1 		$14.6K Sell
95
-4
-4% -$718 ﹤0.01% 6843
2022
Q4 		$13.3K Hold
99
– – ﹤0.01% 6854
2022
Q3 		$20K Buy
99
+2
+2% +$640 ﹤0.01% 7039
2022
Q2 		$34K Sell
97
-2
-2% -$839 ﹤0.01% 7003
2022
Q1 		$58K Sell
99
-37
-27% -$22K ﹤0.01% 7115
2021
Q4 		$125K Buy
136
+13
+11% +$14K ﹤0.01% 6771
2021
Q3 		$154K Sell
123
-43
-26% -$83.4K ﹤0.01% 6474
2021
Q2 		$524K Buy
166
+33
+25% +$131K ﹤0.01% 5388
2021
Q1 		$822K Buy
133
+6
+5% +$43.5K ﹤0.01% 5008
2020
Q4 		$721K Sell
127
-25
-16% -$157K ﹤0.01% 4754
2020
Q3 		$912K Sell
152
-6
-4% -$35K ﹤0.01% 4287
2020
Q2 		$986K Buy
158
+126
+394% +$853K ﹤0.01% 4123
2020
Q1 		$306K Buy
32
+11
+52% +$173K ﹤0.01% 4840
2019
Q4 		$358K Hold
21
– – ﹤0.01% 5244
2019
Q3 		$339K Sell
21
-1
-5% -$16.1K ﹤0.01% 5339
2019
Q2 		$464K Buy
22
+11
+100% +$272K ﹤0.01% 5118
2019
Q1 		$306K Sell
11
-1
-8% -$24K ﹤0.01% 5307
2018
Q4 		$173K Buy
12
+1
+9% +$22.4K ﹤0.01% 5615
2018
Q3 		$381K Buy
11
+10
+1,000% +$309K ﹤0.01% 5128
2018
Q2 		$25K Buy
+1
New +$38.9K ﹤0.01% 6438
2018
Q1 		– Hold
0
– – – 6414

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America's YARW Position: Q1 2026 in Review

Bank of America sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2026, closing a stake of 34 shares — an estimated $973 sold.

Bank of America first reported a position in YARW in Q2 2018 and held it in 31 quarters. The position peaked at $986K in Q2 2020. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Bank of America reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 34 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $973.
  • Bank of America first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2018 and held it in 31 quarters.
  • Bank of America's Yarrow Bioscience, Inc. Common Stock position peaked at $986K in Q2 2020.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.